MedMira Reports Second Quarter Results for FY2016
(firmenpresse) - HALIFAX, NOVA SCOTIA -- (Marketwired) -- 03/24/16 -- MedMira Inc. (MedMira) (TSX VENTURE: MIR) reported today on its financial results for the three and six month periods ended January 31, 2016.
Revenues decreased in the second quarter by 15% compared to the first quarter. The decrease in revenue was due the transition period between the discontinuation of Reveal G3 and the introduction of the new and more advanced Reveal G4 in the United States.
Second Quarter Financial Highlights
About MedMira
MedMira is a leading developer and manufacturer of vertical flow rapid diagnostics. The Company''s tests provide hospitals, labs, clinics and individuals with instant diagnosis for diseases such as HIV and hepatitis C in just three easy steps. The Company''s tests are sold under the Reveal®, Multiplo™ and Miriad™ brands in global markets. Based on its patented Rapid Vertical Flow Technology™, MedMira''s rapid HIV test is the only one in the world to achieve regulatory approvals in Canada, the United States, China and the European Union. MedMira''s corporate offices and manufacturing facilities are located in Halifax, Nova Scotia, Canada. For more information visit . Follow us on and .
This news release contains forward-looking statements, which involve risk and uncertainties and reflect the Company''s current expectation regarding future events including statements regarding possible approval and launch of new products, future growth, and new business opportunities. Actual events could materially differ from those projected herein and depend on a number of factors including, but not limited to, changing market conditions, successful and timely completion of clinical studies, uncertainties related to the regulatory approval process, establishment of corporate alliances and other risks detailed from time to time in the company quarterly filings.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Contacts:
MedMira Inc.
Andrea Young
Corporate Communications
902-450-1588
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 24.03.2016 - 16:30 Uhr
Sprache: Deutsch
News-ID 1424040
Anzahl Zeichen: 2278
contact information:
Contact person:
Town:
HALIFAX, NOVA SCOTIA
Phone:
Kategorie:
Medical Devices
Typ of Press Release:
type of sending:
Date of sending:
Anmerkungen:
Diese Pressemitteilung wurde bisher 227 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"MedMira Reports Second Quarter Results for FY2016
"
steht unter der journalistisch-redaktionellen Verantwortung von
MedMira Inc. (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
